Tesla Shares Decline in Premarket Trading: Cathie Wood's Ark Invest Stays Confident with $14M Purchase Despite Increasing Bearish Sentiment
ARK Investment's Recent Purchases: ARK Investment purchased a total of 39,691 shares across three ETFs, including significant investments in Tesla, despite the company's recent stock decline and bearish market sentiment.
Tesla's Price Target and Market Outlook: ARK continues to project a $2,600 price target for Tesla by 2029, suggesting a potential market cap of $9.75 trillion, while JP Morgan has issued a bearish rating with a $145 price target, indicating a 60% downside.
Concerns Over Tesla's Performance: Tesla's shares have dropped significantly, with analysts warning of a potential 36% loss by June due to weak deliveries and missed expectations, marking the company's worst quarterly performance since 2022.
Investor Sentiment and Market Reactions: Retail sentiment towards Tesla has turned extremely bearish, with concerns about overvaluation and a lack of clarity regarding the company's future prospects, leading to increased caution among investors.
Trade with 70% Backtested Accuracy
Analyst Views on TSLA
About TSLA
About the author

- Delivery and Production Gap: Tesla delivered 358,023 vehicles in Q1, missing the analyst expectation of 370,000 units and marking a 14.4% drop from 418,227 units in the previous quarter, indicating weak demand in the EV market that could hinder future sales growth.
- Inventory Build-Up Issue: The company produced over 408,000 vehicles in Q1, exceeding deliveries by about 50,000 units, which raises concerns about liquidity and may impact Tesla's ability to invest in capital-intensive projects.
- Decline in Energy Storage Business: Energy storage deployments plummeted 38% to 8.8 GWh in Q1, down from 14.2 GWh in the prior quarter, weakening a critical pillar of support for the company's overall growth narrative and potentially affecting investor confidence.
- Capital Expenditure Pressure: Tesla forecasts capital expenditures to exceed $20 billion this year; while the company is making significant investments in AI and robotics, the weak demand in its core automotive business could lead to insufficient future cash flow, increasing financial risk.
- Increased Tesla Holdings: ARK Invest purchased 79,845 shares of Tesla this week for approximately $27.8 million, demonstrating confidence during the stock's pullback, even as Tesla's shares hit a seven-month low, negatively impacting ARKK's overall performance.
- Production Plan Shift: CEO Elon Musk announced that only a few hundred Model S and Model X vehicles remain in inventory, with plans to cease production of these models next quarter and repurpose the Fremont factory for the Optimus humanoid robot, marking a significant strategic shift for the company.
- Delivery Data Insights: Tesla delivered about 16,130 vehicles in the “other models” category in Q1, while Model 3 and Model Y deliveries totaled 341,893, indicating strong performance in high-demand models, yet the overall delivery figures could not offset the stock price decline.
- Market Sentiment and Risks: While ARK continues to accumulate shares, JPMorgan reiterated its 'Underweight' rating, warning of a potential 60% downside for the stock and lowering its 2026 EPS forecast to $1.8, reflecting uncertainties around demand and inventory levels.
- Regulatory Upgrades: The EU's updated GMP Annex 1 emphasizes minimizing human involvement and implementing comprehensive contamination control strategies, requiring manufacturers to assess and mitigate risks across personnel, processes, and environments, thus driving the pharmaceutical industry towards higher compliance standards.
- Intelligent Robotics Application: Nightfood Holdings is advancing AI-driven robotic platforms through TechForce Robotics, combining autonomous functionality with SOP intelligence and real-time deviation detection, aimed at enhancing compliance and operational efficiency in the pharmaceutical sector, reflecting the growing demand for intelligent systems in the industry.
- Persistent Contamination Risks: Despite technological advancements, FDA inspection findings indicate that deficiencies in contamination control and data integrity remain widespread, suggesting that traditional automation approaches have not fully addressed these issues, impacting drug supply chains and patient access to critical medications.
- Market Opportunities Emerge: The pharmaceutical manufacturing sector has been relatively slow to adopt automation, presenting significant market opportunities for technological advancement; Nightfood Holdings' strategic collaboration with Oncotelic Therapeutics aims to develop a GMP-compliant robotics platform, driving the industry's digital transformation.
- New Model Development: Tesla is reportedly developing a new compact SUV that is expected to be priced significantly lower than the Model 3, which could attract more budget-conscious consumers and expand its market share.
- Supplier Engagement: According to a Reuters report, Tesla has reached out to suppliers in recent weeks to discuss the manufacturing process and specifications for the compact SUV, indicating the company's commitment and preparation for the new model.
- Market Reaction: While Tesla shares edged up 0.1% in Thursday's pre-market trading, retail sentiment on Stocktwits trended bearish, reflecting a cautious market outlook regarding the new vehicle.
- Industry Implications: Tesla's compact SUV initiative could impact the entire electric vehicle market, particularly among price-sensitive consumer segments, intensifying competition and driving innovation within the industry.
- New Model Development: Tesla is developing a smaller, lower-cost electric SUV, and while the project is still in its early stages, the company has begun discussions with suppliers regarding manufacturing processes and component specifications, indicating its intent to explore new market segments.
- Market Positioning: The SUV is expected to be shorter than the Model Y and priced significantly lower than the Model 3, which starts at $34,000 in China, aiming to attract a broader consumer base, with initial production likely in China before expanding to the U.S. and Europe.
- Strategic Shift: This move follows CEO Elon Musk's decision to scrap plans for a low-cost EV in 2024 and pivot towards robotaxis and humanoid robots, showcasing the company's adaptability in the electric vehicle market.
- Future Outlook: While it remains unclear if this SUV signifies a return to mass-market vehicles, sources suggest the new model could cater to both human-driven and autonomous driving functionalities, reflecting Tesla's long-term vision for autonomous technology.
- Significant Purchases: ARK Invest acquired nearly 81,000 shares of Tesla over three days during the stock's decline, investing over $28 million, demonstrating ongoing confidence in the electric vehicle market despite volatility.
- Holding Proportion: As of Wednesday, Tesla constituted 8.49% of ARKK ETF's portfolio, remaining its largest holding, even as the stock has fallen 13.9% this month and approximately 24% year-to-date.
- Divergent Analyst Opinions: Despite mixed market sentiment and a cautious Underweight rating from JPMorgan, which flagged rising inventory risks, ARK continues to emphasize autonomous driving as a key component of its long-term investment thesis.
- Weak Market Sentiment: Tesla's stock hit a 2026 low on Tuesday, reflecting ongoing weakness in sentiment towards electric vehicles, battery storage, and AI stocks, as investors remain cautious ahead of the upcoming Q1 earnings report.










